Sigyn Therapeutics Inc (SIGY): yeah I and I own 23% of the float, IF th...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Sigyn Therapeutics Inc (SIGY)

Reply Private New

Keep Last Read

Next 10 Prev Next

PennyStockTrader2

Send PM Follow Ignore

Followers	87
Posts	5520
Boards Moderated	2
Alias Born	07/06/2014

PennyStockTrader2

Re: teampenny post# 614

Thursday, 03/05/2020 7:09:51 AM

Thursday, March 05, 2020 7:09:51 AM

yeah I and I own 23% of the float, IF the float value is accurate which it might be. I still don't have full confidence that this is going to fly, but, it could, and I will continue to trade it (making shares available on rallies and buying back on pullbacks), which will help to add liquidity to the trading which is a good thing, but I will have to be be careful in doing so, which I have attempted to be.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SIGY News

Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:20:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:23:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:25:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 07:34:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 07:48:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 07:23:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:10:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 07:56:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:35:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 03:15:11 PM
Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark Application • InvestorsHub NewsWire • 05/17/2023 11:15:02 AM

More SIGY News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow